Global Needle Biopsy Market Is Expected To Grow At 4.2% In The Forecast Period Of 2021 To 2028

The Needle Biopsy Industry will relinquish an approximated estimate at a frequency of 4.2% for the projection space of 2021 to 2028 with factors such as the surge in prevalence of lung, prostate and breast cancer, rise in government initiatives for awareness about treatment of lung, prostate and breast cancer and increased demand for minimally invasive surgeries. The other factors which are anticipated to propel the growth of the global needle biopsy market include the strategic initiatives by market players and growth potential in emerging economies for needle biopsy and rise in product approvals.

However, the increased cost of needle biopsy and side effects incurred while using needle biopsy and strict regulatory protocols may obstruct the growth of the needle biopsy market in the given forecast period.

Needle Biopsy MarketNeedle Biopsy Market Scenario                                            

According to Data Bridge Market Research, the market for the needle biopsy in North America region has the highest market share followed by Europe and Asia-Pacific. The market leader is Boston Scientific Corporation which accounts an estimated market share of approximately 23.40%. The company has gained outstanding sale through providing needle biopsy for bone cancer, breast cancer and lung cancer treatment and rise of novel minimally invasive needle biopsies.

  • In January 2021, Hologic, Inc acquired SOMATEX Medical Technologies GmbH, a leader in biopsy site biomarkers, for USD 64.00 million. The acquisition funds Hologic Inc. strategy to deliver a varied range of novel solutions for the treatment of breast cancer. Hologic, Inc. would be able to expand the breast cancer marker portfolio.

Trends Impacting the Needle Biopsy Market

Now the question is which other regions Boston Scientific Corporation, Hologic, Inc. and BD are targeting? Data Bridge Market Research has estimated a large growth in North America needle biopsy market and the market leaders targeting the U.S. and Canada to be their next revenue pockets for 2021.

The global needle biopsy market is becoming more competitive with companies such as Boston Scientific Corporation, Hologic, Inc. and BD as they are the top dominating companies in needle biopsy market, having maximum number of net income, acquisitions for production of needle biopsy medications. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global needle biopsy market.

For more analysis on the global needle biopsy market, request for a briefing with our analysts

Global Needle Biopsy Market Development

  • In April 2021, BD announced that the company would be presenting in virtual investor healthcare conferences “The Bank of America Securities 2021 Virtual Healthcare Conference” and "The UBS Global Healthcare Virtual Conference”. This helped company in gaining more customers globally, and improved revenue for future market.

Scope of the Global Needle Biopsy Market

Global needle biopsy market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of Middle East and Africa.

  • All country-based analysis of global needle biopsy market is further analyzed based on further segmentation. On the basis of needle type, the needle biopsy market is segmented into trephine biopsy needles, klima sternal needle, salah needle aspiration needle, jamshidi needle and others. On the basis of ergonomics, the needle biopsy market is segmented into sharp, blunt, quincke, chiba, franseen and others. On the basis of procedure, the needle biopsy market is segmented into fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. On the basis of sample site, the needle biopsy market is segmented into muscles, bones and other organs. On the basis of utility, the needle biopsy market is segmented into disposable and reusable. On the basis of application, the needle biopsy market is segmented into tumour, infection, inflammation and others. On the basis of end user, the needle biopsy market is segmented into hospitals, diagnostic centres, biopsy labs, ambulatory surgical centres, academic and research organizations and others. On the basis of distribution channel, the needle biopsy market is segmented into direct tender and retail sales.

To know more about the study

Key Pointers Covered in Global Needle Biopsy Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Medax SRL
  • Boston Scientific Corporation
  • Cook
  • Hologic, Inc.
  • AprioMed AB
  • Amecath
  • Zamar Care
  • Cardinal Health.
  • INRAD, Inc.
  • BD
  • Möller Medical GmbH
  • HAKKO Corporation
  • Merit Medical Systems
  • weLLgo Medical Products GmbH
  • Swastik Enterprise
  • Tsunami Medical Srl
  • Pajunk
  • B. Braun Melsungen AG

Above are the key players covered in the report, to know about more and exhaustive list of the global needle biopsy market companies’, contact us

Research Methodology: Global Needle Biopsy Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Chief Level Officers, Product and Marketing Managers, Manufacturers, Distributors and Buyers
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@